Annual Report

Overview

The report presents Gland Pharma's FY 2022-23 performance through an Integrated Report prepared under the Integrated Reporting Framework. It reports consolidated revenue from operations of INR 36,246.01 million and a workforce of 4,585 employees. Sustainability highlights include 88.63 GWh of total energy consumed, wastewater treatment and recycling initiatives, ISO 45001 certification, and extensive CSR programs in education, healthcare and conservation.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022-2023
Period: 1 April 2022 – 31 March 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services